Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001599298-24-000135

Chief Accounting Officer acquired 22,026 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anand Bhaskar · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-09-11 Grant or award : show line 1 in the form +22,026 $22.70 $499,990 131,426 D
Loading xslF345X05/wk-form4_1726262759.xml…